ArticleTherapeutic advances in medical oncology2021

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.

Andrea Rocca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.